Journal Based CME - Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer

Treatment of advanced prostate cancer has improved rapidly in the past two decades with the introduction of many new therapeutics including several entirely new therapeutic classes. Whereas androgen deprivation therapy was previously the first and only line of treatment available, modern therapy also routinely employs second-generation anti-androgens, chemotherapy, immunotherapy, radiopharmaceuticals, bone modifying agents, and poly(ADP-ribose) polymerase (PARP) inhibitors, with a resulting substantial increase in patient survival.  This journal-based accredited continuing education (CME) activity focuses on summarizing the current treatment landscape for advanced prostate cancer, with a particular focus on hormone-refractory prostate cancer. 

 

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($0.00)

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

ACCREDITATION

1.00 AMA PRA Category 1 Credit™

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

 

Target Audience

  • Hematologists/Oncologists
  • Oncology Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Physician Assistants
  • Oncology Fellows/Residents
  • Oncology Nurses
  • Researchers and others involved in the care of cancer patients

 

Learning Objectives

Upon successful completion of this journal-based continuing education activity, participants will be able to:

  • Identify recent advances in treatment that have greatly prolonged survival in advanced prostate cancer
  • Identify multiple modalities are now available for treatment of advanced prostate cancer
  • Answer questions remain regarding optimal combination and sequencing of therapies

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 1.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours.
Course opens: 
07/18/2022
Course expires: 
07/18/2023
Cost:
$0.00

This is a journal based continuing education activity. Please read the following article in the International Journal of Cancer Care and Delivery and login to your account on this site to claim credit.  "Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer" authored by Noah S. Younger, MD, PhD, and Hala T. Borno, MD

Link to article here

After reading the article, please return to this page to complete a quiz and evaluation to claim your Continuing Education credits!

Hala Borno, MD - author

Noah Younger, MD, PhD - author

Binay Shah, MD, MHA - planning committee

Committee member(s)

Binay Shah

has no relevant financial relationships to disclose at this time.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 1.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours.

Price

Cost:
$0.00
Please login or register to take this course.

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($0.00) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

CANCELLATION POLICY

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

REFUND POLICY 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued.